Centers for Disease Control, Taipei, Taiwan.
J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.
The early isolated swine-origin influenza A(H1N1)pdm09 viruses were susceptible to oseltamivir; however, there is a concern about whether oseltamivir-resistant influenza A(H1N1)pdm09 viruses will spread worldwide as did the oseltamivir-resistant seasonal influenza A(H1N1) viruses in 2007-2008. In this study, the frequency of oseltamivir resistance in influenza A(H1N1)pdm09 viruses was determined in Taiwan. From May 2009 to April 2011, 1,335 A(H1N1)pdm09-positive cases in Taiwan were tested for the H275Y mutation in the neuraminidase (NA) gene that confers resistance to oseltamivir. Among these, 15 patients (1.1%) were found to be infected with H275Y virus. All the resistant viruses were detected after the patients have received the oseltamivir. The overall monthly ratio of H275Y-harboring viruses ranged between 0% and 2.88%, and the peak was correlated with influenza epidemics. The genetic analysis revealed that the oseltamivir-resistant A(H1N1)pdm09 viruses can emerged from different variants with a great diversity under drug pressure. The ratio of NA/HA activities in different clades of oseltamivir-resistant viruses was reduced compared to those in the wild-type viruses, indicating that the balance of NA/HA in the current oseltamivir-resistant influenza A(H1N1)pdm09 viruses was interfered. It is possible that H275Y-bearing A(H1N1)pdm09 virus has not yet spread globally because it lacks the essential permissive mutations that can compensate for the negative impact on fitness by the H275Y amino acid substitution in NA. Continuous monitoring the evolution patterns of sensitive and resistant viruses is required to respond to possible emergence of resistant viruses with permissive genetic background which enable the wide spread of resistance.
从 2007-2008 年具有抗药性的季节性流感 A(H1N1)病毒在全球传播以来,人们一直担心是否具有抗药性的甲型 H1N1 流感病毒会在全球传播。本研究旨在确定台湾地区甲型 H1N1pdm09 流感病毒对奥司他韦的耐药频率。2009 年 5 月至 2011 年 4 月,对台湾地区 1335 例甲型 H1N1pdm09 阳性病例进行了神经氨酸酶(NA)基因 H275Y 突变检测,该突变可导致对奥司他韦的耐药性。其中,有 15 例(1.1%)患者感染了 H275Y 病毒。所有耐药病毒均在患者接受奥司他韦治疗后检出。H275Y 病毒携带株的总体月检出率介于 0%和 2.88%之间,高峰与流感流行相关。遗传分析显示,奥司他韦耐药的甲型 H1N1pdm09 病毒可以在药物压力下从不同的变体中产生,多样性很大。与野生型病毒相比,耐药病毒 NA/HA 活性的比值降低,表明当前奥司他韦耐药的甲型 H1N1pdm09 病毒中 NA/HA 的平衡受到干扰。具有 H275Y 氨基酸取代的奥司他韦耐药甲型 H1N1pdm09 病毒尚未在全球传播,可能是因为它缺乏必要的许可突变,这些突变可以补偿 NA 中的 H275Y 氨基酸取代对适应性的负面影响。需要对敏感和耐药病毒的进化模式进行持续监测,以应对具有许可遗传背景的耐药病毒的出现,从而使其广泛传播。